Setting 
My Cart

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Toggle Nav
mobile icon
Close
  • Menu
  • Setting
  • Home
  • Search results for: 'research area apoptosis bcl 2 family'

Search results for: 'research area apoptosis bcl 2 family'

Items 231-240 of 329

Page
per page
  1. Tanshinone IIA
    N1846 Tanshinone IIA
    Target: AP-1|MAGL
    Summary: Antioxidant and anti-inflammatory reagent
      insoluble in EtOH; insoluble in H2O; ≥3.42 mg/mL
  2. Tofacitinib (CP-690550) Citrate
    A4135 Tofacitinib (CP-690550) Citrate
     2 Citation
    Target: JAK
    Summary: Potent JAK inhibitor
      ≥25.22 mg/mL
  3. Zebularine
    A1915 Zebularine
     1 Citation
    Target: DNA Methyltransferases|Cytidine deaminases
    Summary: DNA methylation inhibitor
      insoluble in EtOH; ≥50.7 mg/mL
  4. BMS-777607
    A5703 BMS-777607
    Target: MET
    Summary: C-Met inhibitor, potent and selective
      ≥25.65 mg/mL
  5. Cucurbitacin I
    A4512 Cucurbitacin I
    Target: STAT|JAK
    Summary: STAT3/JAK2 signaling inhibitor
      ≥22.45 mg/mL
  6. Cediranib (AZD217)
    A1882 Cediranib (AZD217)
    Target: VEGFR
    Summary: VEGFR inhibitor receptor,highly potent
      ≥22.52 mg/mL
  7. 1-NM-PP1
    B1299 1-NM-PP1
    Target: Cyclin-Dependent Kinases|Bcr-Abl|Src|Ca2 /calmodulin-dependent protein kinases (CaMKs)|c-Fyn
    Summary: Pp60c-src inhibitor
      insoluble in H2O; ≥16.55 mg/mL
  8. BLZ945
    B4899 BLZ945
     1 Citation
    Target: CSF-1R
    Summary: CSF-1R kinase inhibitor
      insoluble in EtOH; insoluble in H2O; ≥19.9 mg/mL
  9. AT13387
    A4056 AT13387
    Target: HSP90
    Summary: Hsp90 inhibitor
      insoluble in H2O; ≥13.25 mg/mL
  10. BMS265246
    A8385 BMS265246
    Target: Cyclin-Dependent Kinases
    Summary: CDK1/2 inhibitor,potent and selective
      insoluble in H2O; insoluble in EtOH; ≥17.25 mg/mL

Items 231-240 of 329

Page
per page
Shop By
Now Shopping by
  1. Specificity Selective Remove This Item
Clear All
Shopping Options
Category
  1. Signaling Pathways 315item
  2. Natural Products 5item
  3. Kits 1 item
  4. Peptides 1 item
  5. Peptides & Proteins 1 item
  6. Lab Reagents 4item
Reversibility
  1. Reversible 22item
  2. Irreversible 12item
Target
  1. Caspases 10item
  2. Cyclin-Dependent Kinases 10item
  3. Adenosine A2A Receptors 2item
  4. Proteasome 3item
  5. Cathepsins 6item
  6. Histone Deacetylases (HDACs) 11item
  7. Inhibitor of apoptosis proteins (IAP) 3item
  8. Akt 2item
  9. Bcl-2 5item
  10. PI3K 4item
  11. CXCR 3item
  12. Raf 4item
  13. Aurora Kinases 6item
  14. Bcl-xl 3item
  15. CSF-1R 1 item
  16. MDM2 2item
  17. EZH2 3item
  18. mTOR 6item
  19. Bromodomains 2item
  20. AP-1 2item
  21. MMP 6item
  22. Androgen Receptors 1 item
  23. Myosin II ATPases 1 item
  24. DT-diaphorases 1 item
  25. FLT3 4item
  26. GSK-3 1 item
  27. Factor Xa 1 item
  28. Farnesoid X receptors (FXRs) 1 item
  29. P-glycoprotein (P-gp) 1 item
  30. PLK 1 item
  31. Chk 3item
  32. Eph Receptors 2item
  33. VEGFR 19item
  34. PDGFR 8item
  35. c-Kit 4item
  36. RET 2item
  37. Phosphodiesterases (PDEs) 2item
  38. Mcl-1 3item
  39. p38 2item
  40. PKB 1 item
  41. JNK 2item
  42. Bcr-Abl 4item
  43. MEK 10item
  44. DOT1L 1 item
  45. FGFR 4item
  46. Pim 1 item
  47. Voltage-gated Sodium (NaV) Channels 1 item
  48. Deubiquitinating enzymes (DUBs) 1 item
  49. Smoothened 1 item
  50. MET 4item
  51. Src 6item
  52. RARs 1 item
  53. Trk Receptors 3item
  54. Aminopeptidases 2item
  55. STAT 1 item
  56. Microtubules/Tubulins 1 item
  57. Estrogen and Related Receptors 1 item
  58. EGFR 8item
  59. Hedgehog 1 item
  60. Reverse Transcriptases 1 item
  61. ROCK 2item
  62. BTK 1 item
  63. RIP kinases 1 item
  64. Monocyte chemotactic proteins 1 item
  65. PAK 1 item
  66. FAK 3item
  67. BMP and Other Activin Receptors 2item
  68. JAK 8item
  69. Syk 1 item
  70. EZH1 2item
  71. DNA-PK 2item
  72. HSP90 4item
  73. AMPK 1 item
  74. PDHK 1 item
  75. CFTR 1 item
  76. TNKS 1 item
  77. Cytochrome P450 (CYP450) 3item
  78. M3 Receptors 1 item
  79. Ksp 1 item
  80. Ribosomes 1 item
  81. Renin 2item
  82. HIV proteases 1 item
  83. Pepsins 1 item
  84. ErbB 2item
  85. S6 kinases 1 item
  86. DNA Methyltransferases 2item
  87. Survivin 1 item
  88. ERK 1 item
  89. c-MET 2item
  90. PKC 1 item
  91. Ubiquitin-specific proteases 1 item
  92. Ca2 /calmodulin-dependent protein kinases (CaMKs) 2item
  93. SMYD2 1 item
  94. SGLT 2item
  95. RAD51 1 item
  96. HER2 1 item
  97. Pyk2 3item
  98. 5-HT2 Receptors 3item
  99. LRRK2 3item
  100. Voltage-gated Calcium Channels (CaV) 1 item
  101. Insulin and Insulin-like Receptors 2item
  102. PARP 1 item
  103. Melanocortin (MC) Receptors 1 item
  104. Sphingosine kinases (SphKs) 1 item
  105. Dehydrogenase 1 item
  106. PKG 1 item
  107. PKA 1 item
  108. Myosin light chain kinases (MLCKs) 1 item
  109. D1 and D5 Receptors 2item
  110. D2 Receptors 2item
  111. D3 Receptors 1 item
  112. 5-HT1 Receptors 1 item
  113. 5-HT7 Receptors 1 item
  114. AdipoR2 1 item
  115. AMPA 1 item
  116. NUAK1 1 item
  117. Integrin-ligand interactions 1 item
  118. NUAK2 1 item
  119. Na /H Exchangers (NHEs) 1 item
  120. MK2 2item
  121. Fatty-acid-binding proteins (FABPs) 1 item
  122. Tie-2 2item
  123. Free Fatty Acid Receptors 1 item
  124. phosphatases 2item
  125. ATM/ATR 1 item
  126. COX 7item
  127. Folate Analogue 1 item
  128. CK2 2item
  129. Guanine nucleotide exchange factors (GEFs) 1 item
  130. 20S proteasomal chymotrypsin 1 item
  131. Geranylgeranyltransferase I 1 item
  132. Farnesyltransferase 1 item
  133. eIF4F 1 item
  134. G9a 1 item
  135. NADPH Oxidases 2item
  136. Calcium-activated chloride channels (CaCC) 1 item
  137. GPR35 1 item
  138. MAGL 1 item
  139. c-Fyn 1 item
  140. Na /K ATPases 1 item
  141. P110 1 item
  142. Hck 1 item
  143. SETD7 1 item
  144. iNOS 1 item
  145. Opioid receptors 1 item
  146. Phospholipases 1 item
  147. TRP Channel 3item
  148. FoxM1 1 item
  149. Apoptosis Inducers 1 item
  150. M2 Receptors 1 item
  151. CB2 Receptors 1 item
  152. Glucocorticoid Receptors 2item
  153. Adenosine A1 Receptors 1 item
  154. 15-lipoxygenases 1 item
  155. eEF-2 1 item
  156. Inward Rectifier Potassium (Kir) Channels 2item
  157. Cdc7 1 item
  158. CMV 1 item
  159. ZAP-70 1 item
  160. Hexokinases 1 item
  161. Flk-1 1 item
  162. Cytidine deaminases 1 item
  163. angiogenesis 1 item
  164. Glucagon Receptors 1 item
  165. DPP-4 2item
  166. c-RET 1 item
  167. FPTase 1 item
  168. p53-MDM2 interaction 1 item
  169. PARs 1 item
  170. c-Fms tyrosine kinase 1 item
  171. PAR 1 item
  172. STK 1 item
  173. IKK 1 item
  174. HCV polymerase 2item
  175. Lyn kinase 1 item
  176. Ftase 1 item
  177. PC-PLC 1 item
  178. cannabinoid receptor 1 item
  179. Rev-Erb Receptors 1 item
  180. Histone Acetyltransferases (HATs) 1 item
  181. DCLK2 1 item
  182. Lck 1 item
  183. PKD 1 item
  184. Bcl-w 1 item
  185. SK 1 item
  186. MST 1 item
  187. Substance P/NK1 Receptor 1 item
  188. gp120/CD4 1 item
  189. MTH1 1 item
Reported Experiments
  1. Animal Experiments 274item
  2. Cell Experiments 186item
Related Disease
  1. Abscesses And Esophageal Candidiasis 1 item
  2. Acute Disseminated Candidiasis 1 item
  3. Acute Myeloid Leukemia 9item
  4. Acute Renal Failure 1 item
  5. Adrenocortical Carcinoma 2item
  6. Advanced Renal Cell Carcinoma 1 item
  7. Autoimmune Diseases 1 item
  8. Biliary Cancer 1 item
  9. Bladder Cancer 3item
  10. Bladder Carcinoma 2item
  11. Bladder Diseases 1 item
  12. B-lymphoid Malignancies 1 item
  13. Breast Cancer 62item
  14. Cancer 168item
  15. Candida Peritonitis 1 item
  16. Candidemia 1 item
  17. Castration-resistant Prostate Cancer 1 item
  18. Cervical Cancer 5item
  19. Cholangiocarcinoma 1 item
  20. Chronic Lymphocytic Leukemia 3item
  21. Chronic Myeloproliferative Disorders 1 item
  22. Clear Cell Renal Cell Carcinoma 1 item
  23. Colon Cancer 17item
  24. Colon Carcinoma 4item
  25. Colorectal Cancer 20item
  26. Diabetes 3item
  27. Diffuse Large B-cell Lymphoma 1 item
  28. Fungal Infection 2item
  29. Glioblastoma 16item
  30. Glioma 7item
  31. HCV 1 item
  32. Hepatitis C 1 item
  33. Hepatocellular Carcinoma 4item
  34. HIV 2item
  35. HIV Infections 2item
  36. Immunological Diseases 1 item
  37. Immunosuppressive Therapy 1 item
  38. Inflammatory Bowel Disease 1 item
  39. Inflammatory Diseases 12item
  40. Leukemia 7item
  41. Liver Cancer 4item
  42. Lung Cancer 21item
  43. Lung Carcinoma 1 item
  44. Lymphoma 11item
  45. Mantle Cell Lymphoma 1 item
  46. Melanoma 17item
  47. Mixed Lineage Leukemia 1 item
  48. Multiple Myeloma 11item
  49. Myelofibrosis 2item
  50. Myeloma 2item
  51. Neuroblastoma 2item
  52. Non-small Cell Lung Cancer 12item
  53. Ovarian Cancer 10item
  54. Pain Relief 1 item
  55. Pancreatic Cancer 23item
  56. Pancreatic Carcinoma 2item
  57. Prostate Cancer 26item
  58. Psoriasis 2item
  59. Pulmonary Fibrosis 2item
  60. Renal Cancer 2item
  61. Renal Cell Carcinoma 4item
  62. Rheumatoid Arthritis 8item
  63. Sarcoma 1 item
  64. Schizophrenia 3item
  65. Soft Tissue Sarcoma 1 item
  66. Squamous Cell Carcinoma 1 item
  67. Testicular Cancer 1 item
  68. Thyroid Cancer 3item
  69. Type 2 Diabetes 8item